CryoLife Announces Release Date and Teleconference Call Details for 2017 Fourth Quarter and Year-End Financial Results
ATLANTA, Feb. 12, 2018 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that 2017 fourth quarter and year-end financial results will be released on Wednesday, March 7, 2018 after the market closes. On Thursday, March 8, 2018 the Company will hold a teleconference call and live webcast at 8:00 a.m. ET to discuss the results, followed by a question and answer session hosted by Pat Mackin, Chairman, President and Chief Executive Officer of CryoLife, Inc.
To listen to the live teleconference, please dial 201-689-8261 a few minutes prior to 8:00 a.m. ET. A replay of the teleconference will be available March 8 through March 15 and can be accessed by calling (toll free) 877-660-6853 or 201-612-7415. The conference number for the replay is 13676706.
The live webcast and replay can be accessed in the Investor Relations section of the CryoLife website at www.cryolife.com and selecting Webcasts & Presentations. In addition, a copy of the earnings press release, which will contain financial and statistical information for the completed quarter and full year, can be accessed in the Investor Relations section of the CryoLife website.
About CryoLife, Inc.Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of medical devices and implantable living tissues used in cardiac and vascular surgical procedures. CryoLife markets and sells products in more than 80 countries worldwide. For additional information about CryoLife, visit our website, www.cryolife.com.
CryoLife D. Ashley Lee Executive Vice President, Chief Financial Officer and Chief Operating Officer Phone: 770-419-3355
View original content with multimedia:http://www.prnewswire.com/news-releases/cryolife-announces-release-date-and-teleconference-call-details-for-2017-fourth-quarter-and-year-end-financial-results-300597460.html
SOURCE CryoLife, Inc.